Adenosine‐5′‐O‐(2‐thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas

No abstract is available for this paper.

• Publication year

  1991

• Venue

  British Journal of Pharmacology

• Publication date

  1991-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1476-5381.1991.tb12223.xPMID 1364829PMCID PMC1917920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides.

  1989cited by this paper
• P2 purinoceptors in the blood vessel wall.

  1989cited by this paper
• Difference in the potentiating effect of adenosine triphosphate and α,β‐methylene ATP on the biphasic insulin response to glucose

  1989cited by this paper
• Difference in the potentiating effect of adenosine triphosphate and alpha, beta-methylene ATP on the biphasic insulin response to glucose.

  1989cited by this paper
• Adenosine 5'-(2-fluorodiphosphate) is a selective agonist at P2-purinoceptors mediating relaxation of smooth muscle.

  1988cited by this paper
• Actions mediated by P2‐purinoceptorsubtypes in the isolated perfused mesenteric bed of the rat

  1988cited by this paper
• Effects of 2-methylthio ATP on insulin secretion in the dog in vivo.

  1988cited by this paper
• Local control of blood pressure by purines.

  1987cited by this paper
• Evidence for two different P2‐purinoceptors on β cell and pancreatic vascular bed

  1987cited by this paper
• Extracellular ATP: effects, sources and fate.

  1986cited by this paper
• Further comparison of contractions of the smooth muscle of the guinea-pig isolated vas deferens induced by ATP and related analogs.

  1986cited by this paper
• ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptor.

  1986cited by this paper
• Potentiating synergism between adenosine diphosphate or triphosphate and acetylcholine on insulin secretion.

  1986cited by this paper
• [Dilator effects of adenosine on rat pancreatic vessels].

  1985cited by this paper
• Effet dilatateur de l'adénosine sur les vaisseaux du pancréas de rat.

  1985cited by this paper
• Is there a basis for distinguishing two types of P2-purinoceptor?

  1985cited by this paper
• Effects of phosphorothioate analogues of ATP, ADP and AMP on guinea‐pig taenia coli and urinary bladder

  1984cited by this paper
• Evidence for purinergic receptors on vascular smooth muscle in rat pancreas.

  1983cited by this paper
• An Introduction to Purinergic Receptors

  1981cited by this paper
• EFFECTS OF PHOSPHATE‐MODIFIED ADENINE NUCLEOTIDE ANALOGUES ON INSULIN SECRETION FROM PERFUSED RAT PANCREAS

  1981cited by this paper
• Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas.

  1979cited by this paper
• [Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide].

  1969cited by this paper
• Coated charcoal immunoassay of insulin.

  1965cited by this paper
• Biological assay.

  1951cited by this paper

• P2-type purinergic signaling in the regulation of pancreatic β-cell functional plasticity as a promising novel therapeutic approach for the treatment of type 2 diabetes?

  2022cites this paper
• P2Y purinergic receptor-regulated insulin secretion is mediated by a cAMP/Epac/Kv channel pathway.

  2015cites this paper
• Purinergic signalling in endocrine organs

  2014cites this paper
• At the center of the circle: purinergic signaling in the autocrine loops of pancreatic islets

  2013cites this paper
• ADP regulation of insulin secretion and beta-cell apoptosis

  2012cites this paper
• Purinergic Signaling, Dyslipidemia and Inflammatory Disease

  2012cites this paper
• Purinergic signalling in the pancreas in health and disease.

  2012cites this paper
• P2Y receptors in health and disease.

  2011cites this paper
• Purinergic Signalling in Pancreatic Islet Endothelial Cells

  2010cites this paper
• ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice

  2010cites this paper
• ADP receptor P2Y13 induce apoptosis in pancreatic β-cells

  2010cites this paper
• Activation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic beta cells.

  2010cites this paper
• P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology.

  2009cites this paper
• Evidence for the possible involvement of the P2Y6 receptor in Ca2+ mobilization and insulin secretion in mouse pancreatic islets

  2008cites this paper
• Uridine diphosphate (UDP) stimulates insulin secretion by activation of P2Y6 receptors.

  2008cites this paper
• P2Y Receptor Mediated Modulation of Insulin Release by a Novel Generation of 2-Substituted-5′-O-(1-Boranotriphosphate)-Adenosine Analogues

  2006cites this paper
• P 2 Y Purinergic Potentiation of Glucose-Induced Insulin Secretion and Pancreatic-Cell Metabolism

  2004cites this paper
• P2Y purinergic potentiation of glucose-induced insulin secretion and pancreatic beta-cell metabolism.

  2004cites this paper
• P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats.

  2003influential citation
• P2Y receptor activation enhances insulin release from pancreatic β-cells by triggering the cyclic AMP/protein kinase A pathway

  2002cites this paper
• Pharmacological evaluation and chemical stability of 2‐benzylthioether‐5′‐O‐(1‐thiotriphosphate)‐adenosine, a new insulin secretagogue acting through P2Y receptors

  2001cites this paper
• Purinergic Receptors and the Pharmacology of Type 2 Diabetes

  2001cites this paper
• P2‐receptor agonists: From molecular recognition studies to potential clinical applications

  2000cites this paper
• 2-Thioether-5'-O-(1-thiotriphosphate)-adenosine derivatives: new insulin secretagogues acting through P2Y-receptors.

  1999cites this paper
• 2-thioether 5'-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-Receptors.

  1999cites this paper
• Evidence that P2X purinoceptors mediate the excitatory effects of alphabetamethylene-ADP in rat locus coeruleus neurones.

  1998cites this paper
• Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell

  1998influential citation
• Physiological Roles for P2 Receptors in Platelets, Visceral Smooth Muscle, and the Immune and Endocrine Systems

  1998cites this paper
• Comparative effects of adenosine‐5′‐triphosphate and related analogues on insulin secretion from the rat pancreas

  1997cites this paper
• Purinergic receptors and metabolic function

  1996cites this paper
• Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats.

  1996cites this paper
• Study of the mechanisms involved in adenosine‐5′‐O‐(2‐thiodiphosphate) induced relaxation of rat thoracic aorta and pancreatic vascular bed

  1996cites this paper
• Effects of Purinoceptor Agonists on Insulin Secretion

  1995cites this paper
• Evidence that tachykinin NK1 and NK2 receptors mediate non‐adrenergic noncholinergic excitation and contraction in the circular muscle of guinea‐pig duodenum

  1995cites this paper
• Purinergic receptors on insulin‐secreting cells

  1994cites this paper
• In Vivo and in Vitro Effects of Adenosine‐5′‐0‐(2‐thiodiphosphate) on Pancreatic Hormones in Dogs

  1994cites this paper
• ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.

  1994cites this paper
• Stimulation of insulin secretion and improvement of glucose tolerance in rat and dog by the P2y‐purinoceptor agonist, adenosine‐5′‐O‐(2‐thiodiphosphate)

  1993cites this paper
• P2y purinoceptor responses of β cells and vascular bed are preserved in diabetic rat pancreas

  1992cites this paper